Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin in breast cancer with brain metastases
NCT03412955Phase 2Unknown
- Sponsor
- Tan Tock Seng Hospital
- Start
- Mar 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of eribulin in breast cancer, sponsored by Tan Tock Seng Hospital. Status: unknown.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03412955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03412955.